These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10226856)

  • 21. Cardioprotection associated with preconditioning in the anesthetized ferret.
    Gomoll AW
    Basic Res Cardiol; 1996; 91(6):433-43. PubMed ID: 8996628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
    Gross GJ; Auchampach JA
    Circ Res; 1992 Feb; 70(2):223-33. PubMed ID: 1310443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state.
    Dana A; Baxter GF; Walker JM; Yellon DM
    J Am Coll Cardiol; 1998 Apr; 31(5):1142-9. PubMed ID: 9562020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
    Przyklenk K; Bauer B; Ovize M; Kloner RA; Whittaker P
    Circulation; 1993 Mar; 87(3):893-9. PubMed ID: 7680290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of adenosine causes myocardial refractoriness.
    Vogt AM; Ando H; Arras M; Elsässer A
    J Am Coll Cardiol; 1998 Apr; 31(5):1134-41. PubMed ID: 9562019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs.
    Yao Z; Rasmussen JL; Hirt JL; Mei DA; Pieper GM; Gross GJ
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):653-63. PubMed ID: 7505370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
    Lott FD; Guo P; Toombs CF
    Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs.
    Toller WG; Kersten JR; Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1999 Nov; 91(5):1437-46. PubMed ID: 10551596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardioprotective effects of ischemic 'preconditioning' are not mediated by adenosine receptors in rat hearts.
    Li Y; Kloner RA
    Circulation; 1993 May; 87(5):1642-8. PubMed ID: 8491020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
    Strasser R; Vogt A; Schaper W
    Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
    Baxter GF; Marber MS; Patel VC; Yellon DM
    Circulation; 1994 Dec; 90(6):2993-3000. PubMed ID: 7994847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs.
    Schwartz LM; Jennings RB; Reimer KA
    Basic Res Cardiol; 1997 Apr; 92(2):106-14. PubMed ID: 9166990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig.
    Louttit JB; Hunt AA; Maxwell MP; Drew GM
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):285-91. PubMed ID: 10028938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of angiotensin in cardioprotective effect of ischemic preconditioning.
    Sharma A; Singh M
    J Cardiovasc Pharmacol; 1999 May; 33(5):772-8. PubMed ID: 10226865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study.
    Baxter GF; Hale SL; Miki T; Kloner RA; Cohen MV; Downey JM; Yellon DM
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):607-14. PubMed ID: 11300361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.
    Budde JM; Velez DA; Zhao Z; Clark KL; Morris CD; Muraki S; Guyton RA; Vinten-Johansen J
    Cardiovasc Res; 2000 Aug; 47(2):294-305. PubMed ID: 10946066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.